Publications by authors named "Baihui Hu"

Claim this Profile
A
A multicenter, randomized, double-blind trial comparing LY01011, a biosimilar, with denosumab (Xgeva®) in patients with bone metastasis from solid tumors.
Mingchuan Zhao, Xichun Hu, Pengpeng Zhuang, Aiping Zeng, Yan Yu, Weihua Yang, Huaqiu Shi, Changlu Hu, Baihui Hu

J Bone Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, Safety, and Immunogenicity of a Biosimilar of Nivolumab (LY01015): A Randomized, Double-Blind, Parallel-Controlled Phase I Clinical Trial in Healthy Chinese Male Subjects.
Wei Wang, Shengnan Zhang, Changlin Dou, Baihui Hu, Hongtao Song, Jie Huang

BioDrugs· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized, Double-Blind, Placebo-Controlled, First-in-Human Clinical Trial to Assess Safety, Tolerability, and Pharmacokinetics of LY-CovMab, a Potent Human Neutralizing Antibody Against SARS-CoV-2.
Qian Zhang, Renpeng Zhou, Jingjing Yang, Changlin Dou, Tianyi Gan, Baihui Hu, Wei Hu

Infect Dis Ther· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis